|Articles|November 14, 2019
TrialScope Shares Findings From 2019 PLS Survey
Advertisement
TrialScope has released results from its 2nd Biennial Plain Language Summaries Survey. The top factors driving sponsors to provide plain language summaries are regulatory requirements, evolving transparency trends and patient engagement initiatives.
To find more of the survey’s findings, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
3
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
